UPDATE : Saturday, February 22, 2020
상단여백
‘Flu vaccine VaxigripTetra fit for upcoming flu season’ by Nam Doo-hyun 2018-08-30 10:47
‘Pharmaceutical stocks to bottom out soon’ by Nam Doo-hyun 2018-08-29 14:34
Chong Kun Dang, Dongkook lead functional foods by Nam Doo-hyun 2018-08-27 15:42
‘Xeomin’s side effect lowest among 5 botulinum toxins’ by Nam Doo-hyun 2018-08-27 14:39
Gilead’s Genvoya comfortably tops HIV treatments by Nam Doo-hyun 2018-08-24 14:33
라인
3 multinationals refuse to take pharma group’s anti-corruption system by Nam Doo-hyun 2018-08-23 12:01
Foreign CEOs to lead Korean units of Novartis, Galderma by Nam Doo-hyun 2018-08-22 13:56
[Special] Pharmaceuticals at odds with government over selective benefit system by Nam Doo-hyun 2018-08-21 15:57
Korea narrows gap with Japan in healthcare IoT patents by Nam Doo-hyun 2018-08-16 15:52
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis? by Nam Doo-hyun 2018-08-16 14:24
라인
Local patents increasingly target obesity by Nam Doo-hyun 2018-08-14 16:26
Who will be first to develop new acute pancreatitis remedy? by Nam Doo-hyun 2018-08-14 10:32
Bio stock slump drags down diagnostics, equipment, reagent companies by Nam Doo-hyun 2018-08-09 14:29
‘Bayer’s liver cancer drug better than expected’ by Nam Doo-hyun 2018-08-06 18:21
2018-listed pharmaceutical, medical shares tank by Nam Doo-hyun 2018-07-31 14:02
라인
Patent approved to predict chemotherapeutic effects for breast cancer patients by Nam Doo-hyun 2018-07-27 11:50
[Exclusive] Invossa patent expired in 6 European countries by Nam Doo-hyun 2018-07-26 11:16
Which multinational drugmaker grew most rapidly in H1? by Nam Doo-hyun 2018-07-25 11:52
Will new patent help detect norovirus easily? by Nam Doo-hyun 2018-07-05 17:24
‘UCB Korea to keep pursuing patient value in neurology’ by Nam Doo-hyun 2018-07-04 14:37
여백
여백
여백
Back to Top